istradefylline (KW-6002)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for istradefylline (KW-6002), covering 2024-04-25 to 2024-04-25. Get the full timeline:
Most recent: Clinical Trial Update: 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa [Phase 2]